CD274 and breast carcinoma: A synergistic effect of OV and PDL1 inhibitor was seen in the study by Chaurasiya et al., where a pox virus, CF33-hNIS-ΔF14, was used in combination with an immune checkpoint inhibitor (anti-PD-L1) using the EO771 murine model of breast cancer.